Fosamax linked to serious health risks

July 28, 2011 - Fosamax is a type of medication known as a bisphosphonate, prescribed for the treatment of bone loss and osteoporosis. In October of 2010 the FDA required all manufacturers of... Read More

Beasley Allen attorney Chad Cook selected to help lead Fosamax consolidated litigation

July 15, 2011 - Wesley Chadwick Cook has been selected to serve on Plaintiffs Steering Committee (PSC) for the consolidated litigation of cases involving the Fosamax Femur Fracture multidistrict litigation... Read More


April 15, 2011 - WHAT IS FOSAMAX? Fosamax (alendronate sodium) manufactured by (Merck & Company) it belongs to a class of medications called bisphosphonates, and they decrease the activity of cells... Read More

New Fosamax safety label warns of bone problems

April 19, 2010 - The osteoporosis drug Fosamax has updated the Warnings, Adverse Reactions, and Patient Information sections of its safety label to revise information on Osteonecrosis of the Jaw (ONJ)... Read More

Merck readies for first Fosamax trial

August 12, 2009 - Merck & Co on Tuesday is slated to fight the first of numerous U.S. lawsuits brought by patients who claim they suffered jaw damage from the company's widely used Fosamax treatment... Read More

Chad Cook on Fosamax Litigation

October 28, 2008 - Chad Cook, lead Fosamax attorney, discusses ongoing Fosamax litigation. Recent studies demonstrate a clear link between osteonecrosis and Fosamax. The irony is that these drugs, such as... Read More

Pharmaceutical Industry Focus on ‘Blockbuster’ Medications

January 28, 2008 - The Los Angeles Times on Sunday examined how the business "strategy that has made the pharmaceutical industry one of the wealthiest and most powerful on Earth" might have begun to "betray... Read More

FDA Says Mercks Fosamax Drug May Lead to Pain

January 7, 2008 - Readington-based Merck & Co.'s Fosamax, Novartis AG's Reclast and similar medicines for thin, weak bones may produce severe joint and muscle pain, U.S. regulators said. Read More

Osteoporosis Drugs to Undergo FDA Safety Review

October 2, 2007 - The Food and Drug Administration (FDA) is going to be taking another look at Fosamax and other bone building drugs because they could be causing irregular heartbeats in some patients. Read More

FDA Conducts Safety Review of Bone Building Drugs

October 1, 2007 - The Food and Drug Administration said Monday it's conducting a safety review of bone-building drugs to see if there's a link to atrial fibrillation, a heart rhythm disorder. Read More

back to top